R&D

News

Awards for AI-based drug R&D continue for second year

UK health technology firm BenevolentAI and the Association of Medical Research Charities are continuing an award encouraging use of artificial intelligence (AI) to develop new therapies for

News

UCB, Roche, and IQVIA take lead in UK life sciences investme...

Pharma giant UCB is to invest around £1 billion in the UK as part of a second life sciences sector deal with the UK government, with industry names such as Roche and IQVIA also committing t

Views & Analysis

Merck & Co’s cancer blockbuster Keytruda funds cutting edge ...

Merck & Co is enjoying blockbuster revenues as its cancer immunotherapy Keytruda is becoming standard of care in a range of cancers.

News

Novartis plans UK headquarters move to London

Novartis is on the move in the UK, relocating its national headquarters from Frimley in Surrey to London to get closer to the capital’s emerging life sciences cluster.

News

Vectura takes £40 million hit as asthma drug fails trial

Vectura has abandoned a late-stage drug in severe uncontrolled asthma after it failed a phase 3 trial, resulting in a decline in its already-depressed share price.

News

Most pharma firms doing little R&D for poorer patients

A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.

Awards for AI-based drug R&D continue for second year

UCB, Roche, and IQVIA take lead in UK life sciences investme...

Merck & Co’s cancer blockbuster Keytruda funds cutting edge ...

Novartis plans UK headquarters move to London

Vectura takes £40 million hit as asthma drug fails trial

Most pharma firms doing little R&D for poorer patients

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

R&amp;D

Editor's Picks

R&D